Goldacre, B; Gray, J; (2016) OpenTrials: towards a collaborative open database of all available information on all clinical trials. Trials, 17 (1). p. 164. ISSN 1745-6215 DOI: https://doi.org/10.1186/s13063-016-1290-8

Herrett, E; Williamson, E; van Staa, T; Ranopa, M; Free, C; Chadborn, T; Goldacre, B; Smeeth, L; (2016) Text messaging reminders for influenza vaccine in primary care: a cluster randomised controlled trial (TXT4FLUJAB). BMJ open, 6 (2). e010069. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2015-010069

Kostkova, P; Brewer, H; de Lusignan, S; Fottrell, E; Goldacre, B; Hart, G; Koczan, P; Knight, P; Marsolier, C; McKendry, RA; +7 more... Ross, E; Sasse, A; Sullivan, R; Chaytor, S; Stevenson, O; Velho, R; Tooke, J; (2016) Who Owns the Data? Open Data for Healthcare. Frontiers in public health, 4. p. 7. ISSN 2296-2565 DOI: https://doi.org/10.3389/fpubh.2016.00007

Matthews, A; Herrett, E; Gasparrini, A; Van Staa, T; Goldacre, B; Smeeth, L; Bhaskaran, K; (2016) Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data. BMJ (Clinical research ed), 353. i3283. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.i3283

Tompson, AC; Petit-Zeman, S; Goldacre, B; Heneghan, CJ; (2016) Getting our house in order: an audit of the registration and publication of clinical trials supported by the National Institute for Health Research Oxford Biomedical Research Centre and the Musculoskeletal Biomedical Research Unit. BMJ open, 6 (3). e009285. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2015-009285

van Staa, TP; Goldacre, B; Buchan, I; Smeeth, L; (2016) Big health data: the need to earn public trust. BMJ (Clinical research ed), 354. i3636. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.i3636

Goldacre, B; (2015) Commentary: Randomized trials of controversial social interventions: slow progress in 50 years. International journal of epidemiology, 44 (1). pp. 19-22. ISSN 0300-5771 DOI: https://doi.org/10.1093/ije/dyv005 Full text not available from this repository.

Goldacre, B; (2015) How to get all trials reported: audit, better data, and individual accountability. PLoS medicine, 12 (4). e1001821. ISSN 1549-1277 DOI: https://doi.org/10.1371/journal.pmed.1001821

Goldacre, B; Brown, T; (2015) Fixing flaws in science must be professionalised. Journal of clinical epidemiology. ISSN 0895-4356 DOI: https://doi.org/10.1016/j.jclinepi.2015.06.018 Full text not available from this repository.

Ramagopalan, SV; Skingsley, AP; Handunnetthi, L; Magnus, D; Klingel, M; Pakpoor, J; Goldacre, B; (2015) Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.gov are associated with the reporting of a statistically significant primary outcome: a cross-sectional study. F1000Research, 4. p. 80. ISSN 2046-1402 DOI: https://doi.org/10.12688/f1000research.6312.2

Finegold, JA; Manisty, CH; Goldacre, B; Barron, AJ; Francis, DP; (2014) What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. European journal of preventive cardiology, 21 (4). pp. 464-474. ISSN 2047-4873 DOI: https://doi.org/10.1177/2047487314525531 Full text not available from this repository.

Goldacre, B; (2014) Preventing bad reporting on health research. BMJ (Clinical research ed), 349. g7465. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g7465

Goldacre, B; (2014) Problems with ABPI proposals to release data on payments to doctors. BMJ (Clinical research ed), 348. g1301. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g1301

Goldacre, B; (2014) Meta-analysis of side effects of statins shows need for trial transparency. BMJ (Clinical research ed), 348. g2940. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g2940

Goldacre, B; (2014) Commentary on berlin et Al. Clinical trials (London, England), 11 (1). pp. 15-8. ISSN 1740-7745 DOI: https://doi.org/10.1177/1740774513515768 Full text not available from this repository.

Goldacre, B; (2014) Evidence on industry influence should be in the core medical curriculum. BMJ (Clinical research ed), 348. g1390. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g1390

Goldacre, B; Godlee, F; Heneghan, C; Tovey, D; Lehman, R; Chalmers, I; Barbour, V; Brown, T; (2014) OPEN DATA CAMPAIGN Open letter: European Medicines Agency should remove barriers to access clinical trial data. BMJ (Clinical research ed), 348. g3768. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g3768

Goldacre, B; Heneghan, C; (2014) Improving, and auditing, access to clinical trial results. BMJ (Clinical research ed), 348. g213. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g213

Goldacre, B; Smeeth, L; (2014) Mass treatment with statins. BMJ (Clinical research ed), 349. g4745. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g4745

Goldacre, BM; (2014) Post all press releases online, and give them named authors. BMJ (Clinical research ed), 348. g3448. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g3448

Goldacre, BM; (2014) NICE must do better at summarising and communicating evidence on statins. BMJ (Clinical research ed), 349. g5081. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g5081

McCartney, M; Goldacre, B; Chalmers, I; Reynolds, C; Mendel, J; Smith, S; Bewley, S; Gordon, P; Carroll, D; Dean, BJ; +5 more... Greenhalgh, T; Heath, I; McKee, M; Pollock, A; Gordon, S; (2014) Why the GMC should set up a central registry of doctors' competing interests. BMJ (Clinical research ed), 348. g236. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.g236

Ramagopalan, S; Skingsley, AP; Handunnetthi, L; Klingel, M; Magnus, D; Pakpoor, J; Goldacre, B; (2014) Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study. F1000Research, 3. p. 77. ISSN 2046-1402 DOI: https://doi.org/10.12688/f1000research.3784.1

Yudkin, JS; Vijan, S; Sussman, JB; Lehman, R; Goldacre, BM; (2014) Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes. Lancet, 384 (9948). p. 1095. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(14)61671-8 Full text not available from this repository.

van Staa, TP; Dyson, L; McCann, G; Padmanabhan, S; Belatri, R; Goldacre, B; Cassell, J; Pirmohamed, M; Torgerson, D; Ronaldson, S; +10 more... Adamson, J; Taweel, A; Delaney, B; Mahmood, S; Baracaia, S; Round, T; Fox, R; Hunter, T; Gulliford, M; Smeeth, L; (2014) The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health technology assessment (Winchester, England), 18 (43). pp. 1-146. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta18430

van Staa, TP; Gulliford, M; Ng, ES; Goldacre, B; Smeeth, L; (2014) Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk? PloS one, 9 (10). e106455. ISSN 1932-6203 DOI: https://doi.org/10.1371/journal.pone.0106455

van Staa, TP; Smeeth, L; Ng, ES; Goldacre, B; Gulliford, M; (2013) The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? Heart (British Cardiac Society). ISSN 1355-6037 DOI: https://doi.org/10.1136/heartjnl-2013-303698

Miron-Shatz, T; Muehlhauser, I; Bower, B; Diefenbach, M; Goldacre, B; Smith, RSW; Spiegelhalter, D; Wegwarth, O; (2011) Barriers to Health Information and Building Solutions. In: Gigerenzer, G; Gray, JAM, (eds.) Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020. MIT Press. ISBN 978-0-26229-985-5 http://researchonline.lshtm.ac.uk/id/eprint/190571 Full text not available from this repository.

van Staa, TP; Goldacre, B; Gulliford, M; Cassell, J; Pirmohamed, M; Taweel, A; Delaney, B; Smeeth, L; (2011) Randomised Evaluations of Accepted Choices in Treatment (REACT) trials: large-scale pragmatic trials within databases of routinely collected electronic healthcare records. [Conference or Workshop Item] https://doi.org/10.1186/1745-6215-12-S1-A104